Join us for a virtual HealthTree Round Table for AML on Saturday, September 17th at 10 am - 11:30 am EST. We will be joined by four AML experts who are going to help us learn about "Decision-Making in AML: What's Next if You Relapse?"
Our panel of AML experts:
These events are education programs for AML patients and caregivers on a variety of treatment and research issues. Each Round Table features presentations from internationally-recognized AML experts who will also participate in extensive Q&A time with audience members. In 2022, these events will take place either in person at a variety of US-based locations or virtually.
Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.
Dr. Eunice Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center. Dr. Wang’s clinical research focuses on the development of early stage clinical trials for acute leukemias (AML, ALL) and myeloproliferative disorders. Her translational research interests involve the development of novel biological therapies targeting the bone marrow microenvironment for myeloid malignancies. Dr. Wang has authored/co-authored over 90 peer-reviewed articles, multiple book chapters, and editorials. In addition to her research, Dr. Wang maintains an active clinical practice.
Dr. Przespolewski treats patients with both malignant and non-malignant blood disorders. This includes patients with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, chronic myeloid leukemia, and myeloproliferative neoplasms. Her research interests include Early Phase Clinical Trials for high-risk myeloid malignancies, as well as translational medicine. Her translational work is focused on understanding how leukemic blasts modulate the local immune system to evade detection, and therefore identifying new therapeutic targets.
Dr. Mendez's research focuses on Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasms (ET, PV), Aplastic Anemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), Clonal cytopenias of Undetermined Significance (CCUS), and Clonal Hematopoiesis of Indeterminate Potential (CHIP).
Professor of Medicine in the Division of Hematology and Oncology and Clinical Director of the Blood and Marrow Transplantation Program at the University of Rochester School of Medicine and Dentistry
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.